Skip to main content
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.130
-0.030 (-0.72%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Whitehawk Therapeutics Revenue

In the year 2025, Whitehawk Therapeutics had annual revenue of $7.15M, down -72.50%.

Revenue (ttm)
$7.15M
Revenue Growth
-72.50%
P/S Ratio
27.28
Revenue / Employee
$310,652
Employees
23
Market Cap
194.92M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20257.15M-18.84M-72.50%
Dec 31, 202425.98M1.63M6.69%
Dec 31, 202324.35M9.14M60.06%
Dec 31, 202215.22M14.10M1,258.57%
Dec 31, 20211.12M-13.46M-92.32%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MacroGenics 149.50M
Karyopharm Therapeutics 146.07M
Precision BioSciences 34.26M
OmniAb 18.67M
Caribou Biosciences 11.16M
Korro Bio 6.39M
Humacyte 2.04M
Revenue Rankings

WHWK News

More News